Company news from ShareCast
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
Applied Nutrition FY profits, revenue rise amid demand from GLP-1 users
Mon 16 November 2026 10:36
(Sharecast News) - Applied Nutrition reported a rise in full-year profit and revenue on Monday amid strong demand from weight-loss medication users and as the protein craze continues, but shares fell as it adopted a cautious stance on the outlook, opting
Applied Nutrition FY profits, revenue rise amid demand from GLP-1 users
Mon 16 November 2026 10:36
(Sharecast News) - Applied Nutrition reported a rise in full-year profit and revenue on Monday amid strong demand from weight-loss medication users and as the protein craze continues, but shares fell as it adopted a cautious stance on the outlook, opting
Victrex taps Adam Butcher for CFO
Mon 16 November 2026 10:11
(Sharecast News) - Speciality polymers manufacturer Victrex announced the appointment of Adam Butcher as chief financial officer and executive director on Monday, with the experienced industrials executive set to join the on 15 February 2027.
Legal & General shares drop despite lifting of FY earnings outlook
Mon 16 November 2026 10:05
(Sharecast News) - Legal & General said on Monday that it was on track to meet or exceed all of the strategic targets it set out in 2024 but shares fell as it reported a mixed performance in the asset management arm and weaker-than-expected pension risk t
Great Portland Estates sells City office scheme for £422m, beating book value
Mon 16 November 2026 09:03
(Sharecast News) - Property group Great Portland Estates has completed the sale of 2 Aldermanbury Square to pension insurer Rothesay for £422.3m, with the transaction completed at a premium to book value and providing additional firepower for future de
Astrazeneca secures EU and US approvals for Klygefa in rare muscle disorder
Mon 16 November 2026 09:02
(Sharecast News) - Drugmaker Astrazeneca said on Monday that its rare disease division Alexion had secured regulatory approvals for Klygefa (gefurulimab) in both the European Union and the United States for the treatment of adults with generalised myasthe
Ceres signs European SOFC manufacturing licence, guides FY revenue to £60m
Mon 16 November 2026 08:57
(Sharecast News) - Ceres Power has signed a new manufacturing licence agreement for its Endura solid oxide fuel cell (SOFC) technology with a an unnamed privately owned European energy technology company, extending its footprint in the region and underpin
Grafton beats UK weakness with growth in Iberia, Ireland
Mon 16 November 2026 07:26
(Sharecast News) - Building supplies group Grafton reported a 2% rise in group revenue in the four months to 31 October, as its Iberian and Irish operations offset a weaker performance in Great Britain, reflecting ongoing weakness in construction activity